Triumvira Immunologics Names Donna Rill Chief Technology Officer

Xconomy Texas — 

Triumvira Immunologics, an Austin, TX-based biotech, appointed Donna Rill to serve as chief technology officer. Triumvera said Rill will use her technology development and manufacturing experience to help drive the company’s clinical development programs to develop a platform for engineering T cells to attack cancers. The company’s lead drug, an experimental treatment for liquid tumors, is expected to start human testing in the first half of 2019. Previously, Rill was vice president of manufacturing for Cell Medica and chief development officer at Opexa Therapeutics.